Decibel Therapeutics, Inc.

Decibel Therapeutics, Inc.verified

DBTX

Price:

$4.91

Market Cap:

$123.37M

Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to address hearing disorders caused by single gene mutations; Gene Therapies for Hair Cell Regeneration designed to replace lost hair cells within the inner ear to address acquired hearing loss and balance disorders; and Otoprotection Therapeutic in clinical development to prevent hearing loss in cancer patients undergoing chemotherapy with cisplatin. T...[Read more]

Industry

Biotechnology

IPO Date

2021-02-12

Stock Exchange

NASDAQ

Ticker

DBTX

The PE Ratio as of June 2024 (TTM) for Decibel Therapeutics, Inc. (DBTX) is -1.93

According to Decibel Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.93. This represents a change of 57.90% compared to the average of -1.22 of the last 4 quarters.

Decibel Therapeutics, Inc. (DBTX) Historical PE Ratio (quarterly & annually)

How has DBTX PE Ratio performed in the past?

The mean historical PE Ratio of Decibel Therapeutics, Inc. over the last ten years is -4.13. The current -1.93 PE Ratio has changed 4.58% with respect to the historical average. Over the past ten years (40 quarters), DBTX's PE Ratio was at its highest in in the December 2022 quarter at -0.80. The PE Ratio was at its lowest in in the December 2020 quarter at -8.09.

Quarterly (TTM)
Annual

Average

-4.13

Median

-3.21

Minimum

-11.08

Maximum

-0.81

Decibel Therapeutics, Inc. (DBTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Decibel Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 244.62%

Maximum Annual PE Ratio = -0.81

Minimum Annual Increase = -82.39%

Minimum Annual PE Ratio = -11.08

Quarterly (TTM)
Annual
YearPE RatioChange
2022-0.81-58.36%
2021-1.95-82.39%
2020-11.08244.62%
2019-3.21-11.17%

Decibel Therapeutics, Inc. (DBTX) Average PE Ratio

How has DBTX PE Ratio performed in the past?

The current PE Ratio of Decibel Therapeutics, Inc. (DBTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-4.61

5-year avg

-4.13

10-year avg

-4.13

Decibel Therapeutics, Inc. (DBTX) PE Ratio vs. Peers

How is DBTX’s PE Ratio compared to its peers?

Decibel Therapeutics, Inc.’s PE Ratio is greater than Werewolf Therapeutics, Inc. (-2.88), greater than Edgewise Therapeutics, Inc. (-14.11), greater than Celcuity Inc. (-7.29), greater than C4 Therapeutics, Inc. (-2.30), less than Aerovate Therapeutics, Inc. (-0.53), greater than Adagene Inc. (-4.73), greater than Acrivon Therapeutics, Inc. Common Stock (-2.33), greater than Rezolute, Inc. (-3.45), less than AN2 Therapeutics, Inc. (-0.95), less than Ikena Oncology, Inc. (-1.18), greater than Eliem Therapeutics, Inc. (-15.77), greater than Anebulo Pharmaceuticals, Inc. (-7.44), less than HCW Biologics Inc. (-0.98), greater than Molecular Partners AG (-4.82),

Build a custom stock screener for Decibel Therapeutics, Inc. (DBTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Decibel Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Decibel Therapeutics, Inc. (DBTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Decibel Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Decibel Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Decibel Therapeutics, Inc. (DBTX)?

What is the highest PE Ratio for Decibel Therapeutics, Inc. (DBTX)?

What is the 3-year average PE Ratio for Decibel Therapeutics, Inc. (DBTX)?

What is the 5-year average PE Ratio for Decibel Therapeutics, Inc. (DBTX)?

How does the current PE Ratio for Decibel Therapeutics, Inc. (DBTX) compare to its historical average?